Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Interval-Brisk Walking in Healthy Older Adults
ISRCTN ISRCTN38841551
ClinicalTrials.gov identifier
Public title Interval-Brisk Walking in Healthy Older Adults
Scientific title
Acronym N/A
Serial number at source 3134
Study hypothesis 1. Can subjects be effectively recruited?
2. Can both exercise therapies (study and control) be safely employed in an older adult population?
3. Can strategies be developed to ensure acceptable patient compliance?
4. Can appropriate quality assurance initiatives (e.g. patient recruitment, staff training, data collection) be developed to ensure the successful completion of a larger study?
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Healthy older adults
Participants - inclusion criteria 1. English literacy
2. Age 65 to 75 years
3. Accessible by telephone
4. Vision and hearing adequate to complete the tasks administered in this study
5. Signed informed consent (not by proxy)
6. Nonsmoker
7. At least 30 minutes of physical activity at least 3 days per week
Participants - exclusion criteria 1. Orthopedic and gait influencing conditions (e.g. severe chronic low back pain)
2. Cognitive deficits (e.g. self-reported diagnosis of Alzheimer’s disease)
3. Medical contraindication to exercise or severe coexisting disease which would interfere with performance
3.1. current cancer
3.2. major surgery within the last year
3.3. current infectious disease
3.4. recent unhealed fractures
3.5. disorders with a highly variable course (e.g. multiple sclerosis)
3.6. falls with fracture
3.7. recurrent falls
3.8. neurologic disease
3.9. seizure disorder
3.10. Huntington’s disease
3.11. Parkinson’s disease
3.12. hepatic failure
3.13. renal failure
3.14. cerebrovascular events
3.15. class A-3 or higher (American College of Sports Medicine [ACSM] 1998).
Anticipated start date 23/06/2005
Anticipated end date 01/09/2005
Status of trial Completed
Patient information material
Target number of participants 10
Interventions An interval-brisk-walking-training program consisting of three sessions per week for 4 weeks. The subjects will participate in a supervised indoor/outdoor training program consisting of repetitions of 30 seconds of brisk walking followed by 3 minutes of recovery walking.

The control group will attend a one-hour training session on the principles of exercise. Participants will be advised to perform moderate endurance exercise at home, such as walking, gardening and swimming three sessions per week for one month.
Primary outcome measure(s) 1. Six-Minute Walk
2. Fifty-Foot Fast Walk
Secondary outcome measure(s) 1. Stroop Color-Word Test
2. Symbol-Digits Modalities Test
3. Five-Minute Walk
4. Repeated Sit-to-Stand
5. Repeated Trunk Flexion
6. Dynamic Balance
7. Medical Outcomes Study Short-form Health Survey 36-items
Sources of funding University of Southampton (UK)
Trial website
Publications
Contact name Prof  Maureen  Simmonds
  Address Professor and Director
School of Physical and Occupational Therapy
McGill University
3654 Promenade Sir-William-Osler
  City/town Montreal, Quebec
  Zip/Postcode H3G 1Y5
  Country Canada
  Tel +1 514 398 8864
  Fax +1 514 398 5439
  Email maureen.simmonds@mcgill.ca
Sponsor University of Southampton (UK)
  Address Highfield
  City/town Southampton
  Zip/Postcode SO17 1BJ
  Country United Kingdom
  Tel +44 (0)2380 59 8672
  Fax +44 (0)2380 59 8671
  Email info@rso.soton.ac.uk
  Sponsor website: http://www.soton.ac.uk/
Date applied 24/06/2005
Last edited 14/09/2009
Date ISRCTN assigned 28/07/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central